Global Congestive Heart Failure Market, By Type (Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure), Stages (Stage I, Stage II, Stage III, Stage IV), Diagnosis (Electrocardiogram, Echocardiogram, MRI, Stress Test, Blood Tests, Cardiac Catheterization, Others), Treatment (Medication, Surgery), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Congestive Heart Failure Market Analysis and Size
The global congestive heart failure market is expected to witness significant growth during the forecast period. Rising prevalence of coronary artery disease and heart attack worldwide and emerging markets are the factors responsible for the growth of this market. Growing cases of hypertension, cardiomyopathy, diabetes and hyperthyroidism drives the congestive heart failure market. Medical advancements which involves ongoing drug discovery, and government and non-government organizational initiatives are what that boosts the market growth. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global congestive heart failure market in the forecast period 2022-2029. The expected CAGR of global congestive heart failure market is tend to be around 7.0% in the mentioned forecast period. The market was valued at USD 21 billion in 2021, and it would grow upto USD 36.08 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Congestive heart failure is the chronic progressive condition that affects the pumping power of the heart muscles. This condition especially refers to the stage in which fluid build-up around the heart & its wall and causes inefficient pumping of blood. Certain condition which causes the CHF are narrow arteries, hypertension, hyperthyroidism, diabetes, smoking & drinking and hyperlipidaemic diseases, which gradually leaves the heart too weak and stiff. Symptoms of CHF included dyspnoea, fatigue and weakness, swelling in legs, ankles & feet, rapid or irregular heartbeat, reduced ability to exercise, swelling of abdomen and chest pain. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period
Congestive Heart Failure Market Scope and Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Type (Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure), Stages (Stage I, Stage II, Stage III, Stage IV), Diagnosis (Electrocardiogram, Echocardiogram, MRI, Stress Test, Blood Tests, Cardiac Catheterization, Others), Treatment (Medication, Surgery), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Aspect Imaging Ltd (Israel), CANON MEDICAL SYSTEMS CORPORATION (Japan), Siemens (Germany), General Electric (U.S.), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Neusoft Corporation (China), ESAOTE SPA (Italy), Medtronic (Ireland), OMRON Corporation (Japan), Dexcom, Inc (U.S.), Abbott (U.S.), Masimo (U.S.),
Global Congestive Heart Failure Market Dynamics
- Increased Initiatives by Government and Market Players
The increasing number of efforts and initiatives that are being initiated by the government and major market leaders all over the world are boosting the market growth. Governments in many countries have launched several healthcare schemes, which, a patient can use for the treatment of several disorders. Furthermore, congestive heart failure being a fatal disease, becoming the reason of mortality for the people all over the world each year. Thus, these policies drive the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
- Increased Incidence of Congestive Heart Failure
As per the records of Organ Procurement and Transplantation Network, 3,582 candidates were on the waiting list for heart transplantation as of June 2020 in the U.S. Thus, increase in number of patient suffering from heart failure has increased the demand for many technologies such as ventricular assist devices, which is anticipated to boost the growth of the market. This creates more opportunity in the market.
- Lack of Skilled Professionals
Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global congestive heart failure market over a forecast period.
- Increasing Cost of Devices
One of the primary factors that are causing a restrain to the congestive heart failure market is the high cost of the devices that occur in installing and operating these devices. There is an increasing number of people that suffers from cardiac disorders all over the world and majority of the population cannot get the optimum benefit of the treatment due to the rising cost.
This global congestive heart failure market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global congestive heart failure market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Congestive Heart Failure Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials. As per the reports from the American College of Cardiology, surveys were submitted from 909 inpatient and outpatient centers who performed cardiac diagnostic procedures in 108 countries. It was witnessed that the procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Thus, decline in number of cardiac surgeries has led to decline in congestive heart failure market forecast.
But, in the post-pandemic era, the market is expected to flourish with the increasing upliftments of hospitals and clinics and the reduction of COVID-19 treatment methods.
Global Congestive Heart Failure Market Scope
The global congestive heart failure market is segmented on the basis of type, stage, diagnosis, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Systolic Heart Failure
- Diastolic Failure
- Left-Sided Heart Failure
- Right-Sided Heart Failure
- Stage I
- Stage II
- Stage III
- Stage IV
- MRI, Stress Test
- Blood Tests
- Cardiac Catheterization
Route of Administration
- Speciality Centres
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Congestive Heart Failure Market Regional Analysis/Insights
The global congestive heart failure market is analysed and market size insights and trends are provided by type, stage, diagnosis, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global congestive heart failure market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to increased geriatric population, and presence of key manufacture of the product. Europe is considered second largest market for congestive heart failure due to high research and development and healthcare expenditure and skilled professionals.
Asia-Pacific dominates the market due to increased prevalence of coronary heart diseases and related disorders and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Congestive Heart Failure Market Share Analysis
The global congestive heart failure market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global congestive heart failure market.
Key players operating in the global congestive heart failure market include:
- Aspect Imaging Ltd (Israel)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Siemens (Germany)
- General Electric (U.S.)
- Hitachi, Ltd. (Japan)
- Koninklijke Philips N.V. (Netherlands)
- Neusoft Corporation (China)
- ESAOTE SPA (Italy)
- Medtronic (Ireland)
- OMRON Corporation (Japan)
- Dexcom, Inc (U.S.)
- Abbott (U.S.)
- Masimo (U.S.)